author-photo

Sandra Muñoz-Galván

Spanish National Research Council

40

Papers

619

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

Identification of a minimal biomarker profile in head-and-neck squamous cell carcinoma tumors

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.

2020 Cells
- Sandra Muñoz-Galván
- Amancio Carnero
Show All
- Source
- Cite
- Save
Citations (9)
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

2020 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (4)
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.

2020 Cells
Show All
- Source
- Cite
- Save
Citations (1)
Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment.

2020 Signal Transduction and Targeted Therapy
Show All
- Source
- Cite
- Save
Citations (6)
Implications of maraviroc and/or rapamycin in a mouse model of fragility.

2020
Show All
- Source
- Cite
- Save
Citations (1)
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

2020 Molecular Cancer
Show All
- Source
- Cite
- Save
Citations (20)
Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment

2019 Oncogene
Show All
- Source
- Cite
- Save
Citations (15)
MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (7)
PO-106 Downregulation of MYPT increases tumorigenesis and resistance to platin drugs in ovarian cancer

2018
Show All
- Source
- Cite
- Save
Citations (0)